Proximal Humerus Site for Anesthesia (NCT01866514) | Clinical Trial Compass
CompletedNot Applicable
Proximal Humerus Site for Anesthesia
United States5 participantsStarted 2013-05
Plain-language summary
This will be a prospective, non-controlled study using healthy adult volunteers as subjects receiving bilateral proximal humerus intraosseous (IO) vascular access to evaluate the insertion technique and IO infusion flow rates.
Who can participate
Age range21 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 21 years or older
* Have no amputation of the upper extremities
* Able to lay flat on table for up to 2 hours
* Self-reported as healthy, as confirmed by the PI
Exclusion Criteria:
* Have an active infection in the body
* Imprisoned
* Pregnant
* Cognitively impaired
* Fracture in humerus, or significant trauma to the site
* Excessive tissue and/or absence of adequate anatomical landmarks in humerus
* Infection in target area
* Humeral IO insertion in past 48 hours, prosthetic limb or joint or other significant orthopedic procedure in humerus
* Current use of anti-coagulants
* Current cardiac condition requiring pacemaker or anti-arrhythmic drugs
* Prior adverse reaction to lidocaine
* Volunteers with any of the following characteristics may be excluded from the infusion pathway evaluation involving administration of contrast dye at the discretion of the PI:
* Prior adverse reaction to contrast dye
* Allergy to any food or drug
* History of impaired renal function
* History of impaired hepatic function
* History of cardiac disease
* History of pheochromocytoma
What they're measuring
1
Intraosseous Infusion Flow Rate
Timeframe: Day 1, within 30 minutes of establishing proximal humerus intraosseous (IO) vascular access